Core Viewpoint - The strategic placement of shares in the initial public offering (IPO) of Jiyuan Group Co., Ltd. has been approved, with a total of 5,001,000 shares to be publicly issued, representing 12.50% of the total post-issue share capital [1][3]. Group 1: Strategic Placement Overview - The initial strategic placement amount is set at 1,000,200 shares, accounting for 20.00% of the total issuance [3][5]. - The strategic placement will involve four investors, with the participation of senior management and core employees through a special asset management plan [5][9]. - The total share capital of the company post-issue will be 40,001,000 shares [3]. Group 2: Investor Participation - The strategic placement is limited to investors who meet specific criteria outlined in the Implementation Rules, ensuring compliance with legal requirements [2][16]. - The senior management and core employees' asset management plan will not exceed 500,100 shares, which is 10% of the total issuance [5][9]. - Other participating investors are allowed to commit up to 60,000,000 yuan [3][5]. Group 3: Compliance and Verification - The underwriter has verified that all participating investors have provided valid documentation and guarantees regarding their qualifications [2][15]. - The strategic placement agreement stipulates that investors will not participate in the preliminary inquiry and will commit to the final issuance price [8][16]. - The lock-up period for shares acquired through the strategic placement is set at 12 months from the date of the IPO [16][28]. Group 4: Investor Profiles - Ningbo Tongshang Hui Gong Industrial Investment Fund, a large enterprise with strategic ties to the issuer, is among the investors [4][23]. - Meinian Health Industry Holding Co., Ltd., a leading health examination company, is also participating, leveraging its extensive data for collaboration [24][28]. - Hangzhou Minsheng Health Pharmaceutical Co., Ltd. is included as well, focusing on health-related products and services [29][30].

高纯度 Omega-3丨 白皮书 核心摘要： 在健康中国战略全面推进的背景下，国民健康管理意识显著提升，健康需求从 "被动治疗"向"主动预防"加 速转型。随着慢性病防控与亚健康改善成为全民健康的核心议题，膳食营养补充剂已成为全民健康管理的重 要工具，其市场发展与科学认知深化同步推进。基于这一现状，本白皮书旨在深入探讨高纯度 Omega-3 在中国居民健康管理中的作用及应用现状，加强公众对其生理功效的认知，为公众提供更加专业的营养指 导。白皮书从以下五个章节展开： 一、中国居民健康管理现状 国家政策推动全民健康管理向主动预防转型，面对慢性病年轻化与全周期防护挑战，需构建监测、干预与营 养支持体系。膳食营养补充剂通过定向支持和免疫力提升，成为公众践行主动健康管理的核心工具，助力实 现从治疗到预防的跨越。 二、膳食营养补充剂市场认知及应用表现 在国民健康管理需求升级与膳食营养补充剂市场快速发展的双轮驱动下，服用膳食营养补充剂已进阶为现代 人健康管理的核心方案。在消费者决策矩阵中，产品本身与品牌背书构成购买双引擎。但不同人群对成分需 求呈现差异化特征，折射精准健康管理趋势。 三、 Omega-3 产品与应用现状 Om ...

Group 1 - The "Second China Health Promotion Conference" was held in Shanghai, focusing on the "National Nutrition Literacy Improvement Plan" to enhance public nutrition health literacy [1][2] - Ganen Group's high-end infant nutrition brand, Ganen, and children's nutrition brand Little Swisse were recognized as excellent units in the children's nutrition literacy improvement initiative [1][2] - The conference featured a strategic cooperation ceremony for the "Children's Nutrition Literacy Improvement Action 2025," highlighting the importance of children's nutrition in national population quality development [2][3] Group 2 - Ganen actively supports the "National Nutrition Literacy Improvement Plan" by collaborating with the China Health Promotion and Education Association to enhance children's nutrition literacy [2][4] - The initiative involves over a hundred maternal and infant chain institutions and includes the launch of a "Children's Precision Nutrition Guide" certification program [2][4] - The "0-6 Years Children's Precision Nutrition Guide" was published to provide scientific and precise nutritional guidance for children aged 0-6 [4][5] Group 3 - Ganen has established a comprehensive nutrition education system based on the guide, including various public awareness campaigns and events [5][6] - The company aims to strengthen the influence of the "0-6 Years Children's Precision Nutrition" initiative and the guide through a multi-level nutrition health education system [6] - Future efforts will focus on optimizing products and creating diverse nutritional combinations to meet the refined parenting needs of the new generation of parents [6]

www.leadleo.com 2025年 中国中药材功能性食品 行业白皮书 从养生青年到银发族群，行业如何破解国民健康焦虑？ 2025 China Herbal Functional Food Industry White Paper ©2025 LeadLeo www.leadleo.com 400-072-5588 白皮书 | 2025/05 中国中药材功能性食品行业 摘要 过去，中药材功能性食品行业以中药材的种 植和基础加工为主，功能食品概念尚处于萌 芽阶段，产品形式较为单一，主要依赖传统 中医药理论和民间经验。 本报告为中国中药材功能性食品行业白皮书， 系统梳理了该行业的全貌与发展脉络，内容 涵盖基础理论、政策环境、市场现状及细分 领域分析四大维度。 ◼ 功能性食品与保健食品的概念相近，广义层 面保健食品属于功能性食品的范畴 如今，中药材功能性食品行业已形成较为完 整的产业链，涵盖种植、研发、生产、销售 等环节，并受益于健康消费升级和政策支持。 消费者对天然、健康产品的追求推动了药食 同源食品的普及，中药食品不再局限于传统 保健品，而是向零食化、便捷化、个性化方 向延伸。然而，行业仍面临产品质量参差 ...

当快节奏生活与健康焦虑交织，当"千篇一律"的营养补充剂难以满足个性化需求，德国Selay以"自然为 本、科技为翼"的革新理念，重新定义膳食补充剂行业——从实验室到餐桌，从细胞健康到生活品质， Selay用每一粒胶囊、每一滴精华，为全球消费者打造"量身定制"的健康未来。 以"Selay精氨酸胶囊"为例，其核心成分玛咖、精氨酸、牡蛎肽和锌，通过科学配比显著改善体力与精 力，用户反馈显示，持续服用可显著提升生活质量。 在Selay的世界里，健康无需妥协——无论是追求极致效率的职场人，还是注重天然养生的家庭主妇； 无论是需要精准营养的银发族，还是渴望由内而外焕发光彩的年轻女性，都能找到属于自己的健康答 案。 Selay，不止于补充剂，更是一种生活态度——以科学之名，与自然共生，让健康成为触手可及的日 常。相信在未来，德国Selay将继续深化科研创新，拓展产品线，为消费者提供更精准、更高效的营养 解决方案，以科学为翼，以自然为根，守护每一个家庭的健康与幸福。 Selay坚信"千人千体"，针对不同人群推出个性化产品线，为中老年人设计的血糖平衡胶囊、芹菜籽胶 囊等，助力心血管与代谢健康；为女性呵护设计的麦角硫因饮、气血饮及 ...

近日，艾瑞咨询基于对婴幼儿配方奶粉行业的深度研究与产品技术分析，正式为高培品牌颁发两项 市场地位证明：高培品牌获得 "小分子氨基酸低敏草饲奶粉中国销量第一"证明，同时旗下爱恩思 获得"全球首款小分子氨基酸乳脂球膜奶粉"证明。该证明通过严谨的企业研究与专家访谈相结合的 方式，全面评估产品配方创新性、技术先进性与市场表现，充分肯定高培在推动婴幼儿奶粉市场升 级中的开创性和领导性贡献。 精准营养时代来临：婴幼儿配方奶粉市场迎来质量变革 中国婴幼儿配方奶粉市场正告别传统营养补充模式，迈向精准营养管理的全新发展阶段。艾瑞咨询 研究显示，氨基酸奶粉作为特殊医学用途配方食品的重要组成部分，呈现强劲增长势头，这一变化 背后反映出消费者需求的深层次转变。 当前市场变革呈现出明显的多重特征：年轻父母对婴幼儿营养的科学性和安全性标准持续攀升， "精准营养"理念逐渐成为消费主流；同时，我国婴幼儿牛奶蛋白过敏（CMPA）发病率的上升趋 势，催生了对低敏感、高吸收专业配方产品的旺盛需求；而蛋白质水解技术、营养素提取工艺等前 沿营养科学的突破性进展，则为产品功能的全面升级奠定了坚实的技术根基。 面对这些市场机遇与挑战，小分子氨基酸奶粉以其 ...

Group 1 - The core viewpoint of the article highlights that Tongrentang has been recognized for its groundbreaking research in precision nutrition, being the only dietary supplement company featured in the Nature supplement on global technology enterprises [1][4] - The article emphasizes that Tongrentang has gradually become a leading player in the global VDS (Vitamins, Dietary Supplements) industry, as evidenced by its repeated appearances in top international journals [4] Group 2 - Tongrentang's precision nutrition research has been notably recognized, including the establishment of China's first fully automated online dry blood spot testing center, which can detect over 40 metabolic components from a simple fingertip blood sample [5] - The company is collaborating with authoritative institutions to develop a new metabolic health assessment model, achieving breakthroughs in multi-dimensional quantification of homeostasis concepts [5] - The focus on scientific evidence is driving the transformation of research outcomes into public health benefits, with an emphasis on addressing common health issues through dietary supplements [6] Group 3 - Tongrentang has conducted significant research on the efficacy of red yeast rice and water-soluble tomato concentrate for cholesterol control and cardiovascular health [7] - The company has innovatively utilized a dual-layer tablet technology to enhance the effectiveness of composite vitamins and minerals [7] - Research has successfully isolated and studied several probiotic strains, exploring their potential benefits for digestive and metabolic health [8] Group 4 - Tongrentang has conducted the first large-scale real-world study in the field of bone and joint health, validating the safety and positive effects of long-term supplementation of glucosamine, chondroitin sulfate, and calcium [8] - The future of precision nutrition is expected to yield more research outcomes that will benefit public health, positioning Tongrentang at the forefront of this emerging field [8]

Core Insights - ADM showcased its innovative health solutions at the 15th China International Health Products Exhibition, emphasizing its commitment to future health and scientific empowerment [1][3] - The company introduced two new probiotic combinations, Balance and Restore, to enhance its scientific nutrition product lineup [1][7] Industry Trends - There is a growing consumer demand for functional nutrition, particularly in areas such as weight management, emotional balance, immune support, and gut health [3] - The HNC event serves as a significant platform for industry collaboration and exploration of future nutritional science [3] Product Offerings - ADM presented a range of clinically supported nutritional solutions targeting key health areas for Chinese consumers, including metabolic health, gut health, emotional health, and skin health [4][5] - Specific solutions include probiotics and postbiotics aimed at managing visceral fat, blood sugar levels, and enhancing gut health across various age groups [4][5] Innovation and Technology - The company highlighted its innovative delivery technology, Flashmelt, which offers a superior taste experience and convenience for probiotic consumption [8] - ADM has established a comprehensive turnkey service platform in China, facilitating the entire process from target definition to commercialization [10] Local Development and Global Integration - Celebrating its 30th anniversary in China, ADM has built a robust local strategy encompassing research, innovation, and manufacturing [12] - The company has successfully integrated global innovations into the Chinese market, exemplified by the approval of the DE111 probiotic strain for food use in China [12] Strategic Vision - ADM aims to provide more than just raw materials by leveraging scientific validation and local R&D to enhance product value and reduce development cycles [13]

高纯度 Omega-3丨 白皮书 核心摘要： 在健康中国战略全面推进的背景下，国民健康管理意识显著提升，健康需求从 "被动治疗"向"主动预防"加 速转型。随着慢性病防控与亚健康改善成为全民健康的核心议题，膳食营养补充剂已成为全民健康管理的重 要工具，其市场发展与科学认知深化同步推进。基于这一现状，本白皮书旨在深入探讨高纯度 Omega-3 在中国居民健康管理中的作用及应用现状，加强公众对其生理功效的认知，为公众提供更加专业的营养指 导。白皮书从以下五个章节展开： 一、中国居民健康管理现状 国家政策推动全民健康管理向主动预防转型，面对慢性病年轻化与全周期防护挑战，需构建监测、干预与营 养支持体系。膳食营养补充剂通过定向支持和免疫力提升，成为公众践行主动健康管理的核心工具，助力实 现从治疗到预防的跨越。 二、膳食营养补充剂市场认知及应用表现 在国民健康管理需求升级与膳食营养补充剂市场快速发展的双轮驱动下，服用膳食营养补充剂已进阶为现代 人健康管理的核心方案。在消费者决策矩阵中，产品本身与品牌背书构成购买双引擎。但不同人群对成分需 求呈现差异化特征，折射精准健康管理趋势。 三、 Omega-3 产品与应用现状 Om ...

TRYING TO FIND THE BEST SOLUTIONS 为 每 个 商 业 难 题 寻 找 最 优 解 TRYING TO FIND THE BEST SOLUTIONS / 报告导读-中国口服美容市场全景扫描：规模、机遇与挑战 2025年，中国口服美容市场进一步扩张、有望突破250亿元，尽管增速较往年有所放缓，但东亚第二大消费市场地位毋庸置疑。 识别到中国消费者的深厚潜力，联合利华、华熙生物、Tuzoo、福瑞达-伽美博士、佰鸿集团、健合集团-Swisse一众海外品牌纷纷开始布局中国市场：新西兰口服美容品 牌Tracel亮相第七届中国国际进口博览会、澳大利亚女性健康品牌Kynd宣布将加速布局中国市场、Swisse举办全球细胞新生巅峰论坛......众多品牌瞄准中国消费者摩拳 擦掌，新一轮美业"大战"一触即发。 与此同时，中国口服美容市场产品端抗衰、美白消费需求持续增长、成为口服美容主要细分市场，相关产品不断涌现；行业格局方面，中国口服美容市场体量庞大，但 行业集中度高。 此外，相关政策法规的逐步完善，侧面加速行业洗牌，线上渠道销售占比显著提升，新兴内容电商以"低价+场景化内容"领跑销量，成分党消费 ...